Agents for R&D: Cutting through the hype

​As agentic AI begins to take on real work across the drug development lifecycle, this evening will cut through the hype and show you what that looks like in practice.

​We're bringing together founders and practitioners to show real problems, real solutions, and exactly how they built them so you can take ideas straight back to your company.

​What to Expect:

• ​Opening perspective on where AI stands today and how agentic systems are beginning to drive real outcomes in biotech

• ​Live demos with Q&A

• ​Open networking with fellow biotech founders, operators, and AI builders

• ​Space generously provided by Pillar VC

• ​Dinner and drinks included

​The Evening:

• ​5:00pm — Food, drinks, and mingling

• ​6:00pm — Opening talk + demos with Q&A from:

  • ​Ashoka Rajendra - CEO, Orchestra

  • ​Stuart Ince, VP of Program Leadership & Operations, Accent Therapeutics

  • ​Dan Price, VP of Computational Biology, Nimbus Therapeutics

  • ​Jon Lee, VP of Clinical Development, Pheon Therapeutics

  • ​Adam Kraut, Director of Research Informatics & Data Architecture, Metaphore Bio

  • ​Stacy Chin, Co-Founder of Scoutgrants.ai

• ​7:00pm — Mingling and learning how to build agents

​Who This Is For:

​Biotech founders, management, and operators who are curious about using AI in their companies and want to walk away with a concrete sense of what's possible and where to start.

​About Orchestra Bio:

​Orchestra's mission is to reduce the operational complexity of drug development. The company builds and deploys agents to help manage R&D programs and operations. Learn more at orchestra.bio.